Compare Snap On Incorporated (SNA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs Zimmer Biomet Holdings Inc — how do they compare? Snap On Incorporated trades at $360.37 (market cap $18.56B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Snap On Incorporated and Zimmer Biomet Holdings Inc are close in size by market cap, and Snap On Incorporated pays the higher dividend (2.72%). Which is the better fit depends on your goals — on Pluang, investors hold Snap On Incorporated for 37 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| SNA | ZBH | |
|---|---|---|
Market Cap | $18.56B | $16.95B |
Volume | 401,326 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $419.31 | $103.98 |
52-Week Low | $327.33 | $79.58 |
Typical Hold Time | 37 Days | 89 Days |
Enterprise Value | $18.20B | $24.02B |
Dividend Yield | 2.72% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap-On Incorporated (SNA) trades at $358.88, down 0.28% with bearish technical signals from moving averages and oscillators. The company maintains strong fundamentals with 19.6% net income margin and 17.58% ROE, though Q1 2026 earnings missed expectations. Recent news highlights institutional position adjustments and gross margin expansion to 51.4% driven by RCI initiatives and volume growth.
Analyst consensus remains bullish with a $449 price target (66.7% buy ratings), but technical weakness and premium valuation create near-term headwinds. Key risks include integration costs from the Diesel Laptops acquisition and softer OEM demand, while strong cash flow generation and dividend payments provide shareholder value support.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
